SK Biopharmaceuticals Co Ltd
Common Name
SK Biopharmaceuticals
Country
South Korea
Sector
Healthcare
Industry
Biotechnology
Employees
246
Ticker
326030
Exchange
KOREA EXCHANGE
Website
www.skbp.comDescription
Sk Biopharmaceuticals Co., Ltd. is a leading biomedical company primarily engaged in the research, development, and commercialization of innovative pharmaceutical products. This company operates with ... Sk Biopharmaceuticals Co., Ltd. is a leading biomedical company primarily engaged in the research, development, and commercialization of innovative pharmaceutical products. This company operates with a strong focus on central nervous system (CNS) disorders, aiming to address unmet medical needs through its proprietary drug development programs. One of its notable achievements includes the development of therapies for epilepsy and Parkinson's disease, which highlights its commitment to advancing treatments in the CNS sector. Additionally, Sk Biopharmaceuticals is actively expanding its portfolio through strategic partnerships and collaborations in the biopharmaceutical industry. By leveraging advanced research facilities and a robust pipeline of clinical stage assets, the company plays a significant role in contributing to the pharmaceutical market's landscape. Its presence is crucial in enhancing the availability of targeted therapies, ultimately improving patient outcomes across global healthcare systems.
SK Biopharmaceuticals's Waste Data Preview
In 2023, SK Biopharmaceuticals conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Waste Generated | 0000000 | Copy/Paste is a PRO feature.  a | Copy/Paste is a PRO feature. a | 0000000 |
Total Waste Recovered | Copy/Paste is a PRO feature.  | 0000000 | Copy/Paste is a PRO feature. | 0000000 |
Total Hazardous Waste Generated | 0000000 | 0000000 | Copy/Paste is a PRO feature. a | 0000000 |
Non-Hazardous Waste Disposed | Copy/Paste is a PRO feature. | Copy/Paste is a PRO feature. | 0000000 | 0000000 |
Limited Data Preview
You are viewing a limited preview of SK Biopharmaceuticals’s Waste Management dataset. The full dataset, available for download, includes total waste generated, broken down by hazardous and non-hazardous streams, along with reported recovery and disposal figures with historical coverage back to 2021.
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Verified Sources Behind SK Biopharmaceuticals’s Waste Management Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore SK Biopharmaceuticals’s data sources below and access millions more through our Disclosure Search.
a. SK Biopharmaceuticals's Sustainability Report 2024
Want Full Access to SK Biopharmaceuticals's Waste Management Dataset?
Explore Peer Companies
Celltrion Inc
Healthcare
Biotechnology
South Korea
Samsung Biologics Co Ltd
Healthcare
Biotechnology
South Korea
HLB Inc
Healthcare
Biotechnology
South Korea
InnoCare Pharma Ltd
Healthcare
Biotechnology
China (Mainland)
Frontage Holdings Corp
Healthcare
Biotechnology
United States
Insmed Inc
Healthcare
Biotechnology
United States